Monoclonal antibody shows potential for lupus nephritis treatment.
Combination therapy for advance endometrial carcinoma.
NHE3 inhibitor administered as 50 mg oral tablets.
Investigational oral MET kinase inhibitor from Merck.
Oral supplements for metabolic disorder.
First generic specialty injections approved for Novadoz Pharmaceuticals.
Cariprazine demonstrated greater improvement on the MADRS.
First new drug approval for the condition in nearly a decade.
Black box warns of increased risk of blood clots and death.
First oral drug for advanced or metastatic bladder cancer.